in blue. No. ORI 94/2018 10 November 2018 Subject: Resolution of the Board of Directors' Meeting No. 12/2561 Adjustment of the Exercise Ratio by adjusting Number of ORI-W1 and approval of the asset
does not include (1) the existing types of securities under the Securities and Exchange Act B.E. 2535; and (2) instruments representing rights pursuant to an agreement of contract where the right is
2017 and Annual Report of the Board of Directors in relation to the Company operating result in respect of the year 2017, which is subject to the approval of the Annual General Meeting of Shareholders No
mutual fund had been given an approval by the Office in accordance with the rules, conditions and procedures as specified in the notification of the SEC.
Supervisory Board No. Tor Jor. 15/2563 Re: Application for Approval and Granting of Approval for Offer for Sale of Newly Issued Shares (No. 8) By virtue of Section 16/6 of the Securities and Exchange Act B.E
Securities Sheft Approval Investor Alert Securities Reference Info Listed Company Last updated on 13 January 2025
contains subject matters for consideration as follows: Agenda Item 1: Consideration for approval of a one-year extension of the maturity date; Agenda Item 2: Consideration for approval of a partial
meeting agenda contains subject matters for consideration as follows: Agenda Item 1: Consideration for approval of an extension of the maturity date and a partial repayment of the principal; Agenda Item 2
Item 1: consideration for approval of an extension of the bond maturity dates for a period of two years; Agenda Item 2: consideration for approval of partial repayment of the principals of the bonds